We are monitoring the impact of COVID-19 & Recession alarm on Europe Biobanks Market Get in touch with us for detailed analysis Know More
Share on

Europe Biobanks Market Research Report – Segmented By Product Type, Sample Type, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 442
Pages: 142

Europe Biobanks Market Size (2022 to 2027)

The size of the European biobanks market is forecasted to grow USD 83.15 million by 2027 from USD 58.24 million in 2022, registering at a CAGR of 7.38% between 2022 to 2027.

Factors such as the growing prevalence of chronic illnesses and government and non-governmental organizations supporting and investing in R&D are projected to propel the market forward over the forecast period. The area is being driven by large investments in R&D for advanced medicines such as personalized medicine and cancer genomics research. Furthermore, the emergence of COVID-19 has positioned Biobanks at the forefront of pandemic preparedness efforts, leading in market organic revenue growth. Biobanks have long been an important part of biomedical research. There have been several advancements in platforms and technologies used in genetic investigations during the last few decades. Clinical labs have increased their need for biospecimens to develop tests for genetic testing due to this. In addition, biobanks assist people in improving their health by reducing drug reactions and providing personalized medicines.

The European Science Foundation has been a key contributor to advances in stem cell and regenerative medicine research and the development of new treatments and opportunities for diseases that are currently incurable. With more people becoming aware of stem cell treatments, a growing number of parents are opting for umbilical cord banks for their children. Biobanks are useful not just for genetic illness treatments but also for medical research into uncommon genetic disorders. The European Biobanks market is growing due to rising awareness of stem cell treatments and advancements in regenerative medicine. In addition, the government is taking several steps to encourage regenerative medicine research, which is likely to help the biobanking market's growth. The demand for cost-effective drug delivery and development is increasing, which is propelling the industry forward.

The expansion of the European biobanks market might be restricted by high method costs and a lack of standardization. Furthermore, because of the variety of biological samples maintained in Biobanks, developing a unique procedure for them may be a difficult undertaking. The cost of the approach varies depending on the kind of sample.

Obstacles such as high levels of poverty, poor literacy rates, and traditional behaviors obstruct the consequences. Furthermore, a shortage of medical ethics training and counseling for biobank personnel is another issue that is challenging the market's growth.

This research report on the European Biobanks market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Equipment
  • Consumables

By Sample Type: 

  • Human Tissues
  • Stem Cells
  • DNA Or RNA
  • Bio-fluids
  • Others

By Application: 

  • Therapeutic Applications
  • Research Applications
  • Clinical Trials

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European biobanks market is expected to account for a substantial share in the global market during the forecast period. Due to significant government spending, growth in the number of chronic illnesses, and increased research activities and drug development procedures in the area, Europe has the greatest market for Biobanks. In 2020, Europe led the market, with maximum market share. The existence of well-established Biobanks in Nordic nations such as Sweden, Norway, Denmark, and others is credited with this supremacy. Continuous R&D efforts by European pharmaceutical companies are also one reason behind the region's increased market share. In addition, stem cell research is becoming more popular in Europe, and it is helping to find new treatments for a variety of ailments. Over the last decade, stem cell research has enabled several advancements in regenerative medicine. As a result, it has become one of the most important treatments for diseases including Alzheimer's, diabetes, cancer, and rare genetic disorders.

KEY MARKET PLAYERS:

The most promising companies in the European Biobanks Market profiled in this report are Beckman Coulter, Tecan group, Taylor- Wharton, Panasonic biomedical, Teva Pharmaceuticals, Biolife Solutions, Custom biogenic systems, Princeton cryotech, Fluidx, Tissue solutions, Wildcat laboratory solutions, Micronik and Brooks life science systems.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Product Type                                       

                                5.1.1 Equipment’s                           

                                                5.1.1.1 Temperature control systems     

                                                5.1.1.2 Incubators           

                                                5.1.1.3 Centrifuges         

                                                5.1.1.4 Alarm and Monitoring Systems  

                                                5.1.1.5 Accessories         

                                                5.1.1.6 Other Equipment's          

                                5.1.2 Consumables                         

                5.2 By Sample Type                                        

                                5.2.1 Human Tissues                      

                                5.2.2 Stem Cells               

                                5.2.3 DNA or RNA                            

                                5.2.4 Bio-fluids                 

                                5.2.5 Other Sample Type                             

                5.3 By Application                                           

                                5.3.1 Therapeutic Applications                  

                                5.3.2 Research Applications                        

                                5.3.3 Clinical Trials                           

6. Geographical Analysis                                                              

                                6.1 Introduction                               

                                6.2 U.K                 

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Beckman Coulter                                     

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Tecan group                                               

                8.3 Taylor- Wharton                                       

                8.4 Panasonic biomedical                                             

                8.5 Teva pharmaceuticals                                            

                8.6 Biolife solutions                                        

                8.7 Custom biogenic systems                                     

                8.8 Princeton cryotech                                  

                8.9 Fluidx                                            

                8.10 Tissue solutions                                      

                8.11 Wildcat laboratory solutions                                             

                8.12 Micronik                                    

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. Europe BioBanks Market, By Region, From 2022 - 2027 (USD Million)
  2. Europe BioBanks Market, By Product Type, From 2022 - 2027 (USD Million)
  3. Europe Equipment's Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Equipment's Market, By Equipment Type, From 2022 - 2027 (USD Million)
  5. Europe Temperature control systems Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Incubators Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Centrifuges Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Alarm and Monitoring Systems Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Accessories Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Other Equipment's Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe Consumables Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe BioBanks Market, By Sample Type, From 2022 - 2027 (USD Million)
  13. Europe Human Tissues Market, By Region, From 2022 - 2027 (USD Million)
  14. Europe Stem Cells Market, By Region, From 2022 - 2027 (USD Million)
  15. Europe DNA or RNA Market, By Region, From 2022 - 2027 (USD Million)
  16. Europe Bio-fluids Market, By Region, From 2022 - 2027 (USD Million)
  17. Europe Other Sample Type Market, By Region, From 2022 - 2027 (USD Million)
  18. Europe BioBanks Market, By Application, From 2022 - 2027 (USD Million)
  19. Europe Therapeutic Applications Market, By Region, From 2022 - 2027 (USD Million)
  20. Europe Research Applications Market, By Region, From 2022 - 2027 (USD Million)
  21. Europe Clinical Trials Market, By Region, From 2022 - 2027 (USD Million)
  22. U.K BioBanks Market, By Product Type, From 2022 - 2027 (USD Million)
  23. U.K Equipment's Market, By Equipment Type, From 2022 - 2027 (USD Million)
  24. U.K BioBanks Market, By Sample Type, From 2022 - 2027 (USD Million)
  25. U.K BioBanks Market, By Application, From 2022 - 2027 (USD Million)
  26. Spain BioBanks Market, By Product Type, From 2022 - 2027 (USD Million)
  27. Spain Equipment's Market, By Equipment Type, From 2022 - 2027 (USD Million)
  28. Spain BioBanks Market, By Sample Type, From 2022 - 2027 (USD Million)
  29. Spain BioBanks Market, By Application, From 2022 - 2027 (USD Million)
  30. Germany BioBanks Market, By Product Type, From 2022 - 2027 (USD Million)
  31. Germany Equipment's Market, By Equipment Type, From 2022 - 2027 (USD Million)
  32. Germany BioBanks Market, By Sample Type, From 2022 - 2027 (USD Million)
  33. Germany BioBanks Market, By Application, From 2022 - 2027 (USD Million)
  34. Italy BioBanks Market, By Product Type, From 2022 - 2027 (USD Million)
  35. Italy Equipment's Market, By Equipment Type, From 2022 - 2027 (USD Million)
  36. Italy BioBanks Market, By Sample Type, From 2022 - 2027 (USD Million)
  37. Italy BioBanks Market, By Application, From 2022 - 2027 (USD Million)
  38. France BioBanks Market, By Product Type, From 2022 - 2027 (USD Million)
  39. France Equipment's Market, By Equipment Type, From 2022 - 2027 (USD Million)
  40. France BioBanks Market, By Sample Type, From 2022 - 2027 (USD Million)
  41. France BioBanks Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample